Revelation Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LINDEN ADVISORS LP | 02/14/2025 | 338,110 | $2,513 | 0.00% | 12.62% |
YAKIRA CAPITAL MANAGEMENT, INC. | 02/13/2025 | 246,884 | $1,728 | 0.00% | 9.21% |
PINE VALLEY INVESTMENTS LTD LIABILITY CO | 02/04/2025 | 99,290 | $695 | -30.15% | 3.70% |
WALLEYE TRADING LLC | 02/13/2025 | 93,435 | $654 | -11.01% | 3.49% |
WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 54,752 | $383 | 146.61% | 2.04% |
JANE STREET GROUP, LLC | 02/14/2025 | 50,000 | $350 | 0.00% | 1.87% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 10,354 | $72 | -34.53% | 0.39% |
WALLEYE CAPITAL LLC | 02/13/2025 | 10,074 | $71 | -94.61% | 0.38% |
UBS GROUP AG | 02/14/2025 | 2,512 | $18 | -5.85% | 0.09% |
POM INVESTMENT STRATEGIES, LLC | 01/29/2025 | 1,005 | $7 | 0.00% | 0.04% |
Revelation Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 15 institutional investors and hedge funds held shares of Revelation Biosciences, Inc.. The most heavily invested institutionals were:
LINDEN ADVISORS LP: 338,110
Yakira Capital Management, Inc.: 246,884
Pine Valley Investments Ltd Liability Co: 99,290
Walleye Trading LLC: 93,435
WOLVERINE ASSET MANAGEMENT LLC: 54,752
JANE STREET GROUP, LLC: 50,000
35.25% of Revelation Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.49 M shares in the last 24 months. This purchase volume represents approximately $14,872 in transactions.